News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
15,649 Results
Type
Article (469)
Company Profile (4)
Press Release (15176)
Section
Business (8023)
Career Advice (12)
Deals (1020)
Drug Delivery (2)
Drug Development (1380)
Employer Resources (7)
FDA (276)
Job Trends (445)
News (10043)
Policy (420)
Tag
Academia (34)
Accelerated approval (1)
Allergies (4)
Alliances (439)
Alzheimer's disease (20)
Antibody-drug conjugate (ADC) (3)
Approvals (285)
Artificial intelligence (4)
Bankruptcy (6)
Best Places to Work (423)
Biosimilars (3)
Biotechnology (2)
Bladder cancer (6)
Breast cancer (11)
Cancer (80)
Cardiovascular disease (2)
Career advice (10)
CAR-T (3)
Cell therapy (8)
Cervical cancer (2)
Clinical research (1234)
Collaboration (9)
Compensation (6)
COVID-19 (57)
C-suite (1)
Cystic fibrosis (3)
Data (141)
Depression (1)
Diabetes (11)
Diagnostics (225)
Digital health (2)
Diversity, equity & inclusion (2)
Drug pricing (3)
Duchenne muscular dystrophy (1)
Earnings (7966)
Employer resources (7)
Events (1704)
Executive appointments (3)
FDA (414)
Frontotemporal dementia (1)
Funding (9)
Gene editing (1)
Generative AI (1)
Gene therapy (8)
GLP-1 (23)
Government (33)
Guidances (103)
Healthcare (565)
Immunology and inflammation (4)
Indications (1)
Infectious disease (61)
Inflammatory bowel disease (5)
Influenza (2)
Intellectual property (3)
Interviews (2)
IPO (808)
Job creations (36)
Job search strategy (10)
JPM (1)
Labor market (1)
Layoffs (12)
Legal (67)
Liver cancer (2)
Lung cancer (13)
Lymphoma (23)
Management (2)
Manufacturing (7)
MASH (2)
Medical device (534)
Medtech (535)
Mergers & acquisitions (223)
Metabolic disorders (24)
Multiple sclerosis (9)
Neurodegenerative disease (4)
Neuropsychiatric disorders (1)
Neuroscience (35)
NextGen: Class of 2026 (101)
Non-profit (47)
Now hiring (1)
Obesity (9)
Ovarian cancer (2)
Pain (4)
Pancreatic cancer (1)
Patents (4)
Patient recruitment (1)
Peanut (1)
People (384)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase 1 (311)
Phase 2 (459)
Phase 3 (590)
Pipeline (358)
Policy (1)
Postmarket research (27)
Preclinical (97)
Press Release (2)
Prostate cancer (1)
Radiopharmaceuticals (5)
Rare diseases (10)
Real estate (51)
Recruiting (4)
Regulatory (358)
Research institute (43)
Resumes & cover letters (1)
Rett syndrome (1)
RSV (1)
Sickle cell disease (1)
Spinal muscular atrophy (13)
Startups (40)
Vaccines (15)
Venture capital (1)
Weight loss (8)
Women's health (3)
Date
Last 7 days (22)
Last 30 days (49)
Last 365 days (922)
2026 (61)
2025 (928)
2024 (1063)
2023 (1229)
2022 (3827)
2021 (1340)
2020 (1267)
2019 (916)
2018 (826)
2017 (617)
2016 (355)
2015 (500)
2014 (351)
2013 (157)
2012 (199)
2011 (216)
2010 (275)
Location
Africa (13)
Alabama (4)
Arizona (4)
Asia (823)
Australia (102)
California (400)
Canada (93)
China (11)
Colorado (17)
Connecticut (7)
Delaware (18)
Europe (1866)
Florida (39)
Georgia (11)
Illinois (28)
Indiana (19)
Japan (2)
Kentucky (1)
Louisiana (2)
Maine (5)
Maryland (20)
Massachusetts (223)
Michigan (49)
Minnesota (21)
Nevada (2)
New Hampshire (3)
New Jersey (91)
New York (93)
North Carolina (44)
Northern California (267)
Ohio (7)
Pennsylvania (63)
South America (15)
Southern California (110)
Tennessee (3)
Texas (44)
United States (1238)
Utah (11)
Virginia (4)
Washington State (35)
Wisconsin (2)
15,649 Results for "255".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Agilent Announces Cash Dividend of 25.5 Cents Per Share
November 20, 2025
·
1 min read
Press Releases
AB Science announces the successful completion of a 2.55 million euros private placement
August 4, 2025
·
11 min read
IPO
Upstream Raises $255M IPO for Inflammatory Drugs; CAMP4 Nets $75M for RNA Work
Two biotechs set out for the public markets this week, with Upstream Bio raising $255 million for its inflammatory disease work, while CAMP4 Therapeutics picked up $75 million to develop RNA-targeting drugs.
October 11, 2024
·
1 min read
·
Annalee Armstrong
Press Releases
Valspring Capital Successfully Closes Fund I Above Target at $255 Million
January 9, 2025
·
3 min read
Press Releases
Dermata Therapeutics Announces $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules
January 23, 2025
·
5 min read
Press Releases
Dermata Therapeutics Announces Closing of $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules
January 23, 2025
·
5 min read
Biotech Bay
Actym Closes $59.5 Million Series A with New $25.5 Million Extension
Actym Therapeutics adds $25.5 million to close its Series A with $59.5 million total New investor GKCC LLC joins syndicate Capital will propel lead program ACTM-838 into first-in-human oncology trial and further advance proprietary STACT platform.
October 18, 2023
·
3 min read
Deals
Evelo Biosciences Closes $25.5 Million Private Placement
Evelo Biosciences, Inc. today announces that it closed the previously announced private placement, resulting in gross proceeds of approximately $25.5 million from the sale of 11,025,334 shares of its common stock at a purchase price of $2.31 per share.
July 12, 2023
·
6 min read
Biotech Bay
Nektar and Collaborators Present Preclinical Data on NKTR-255 Combined with Obinutuzumab in Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting
Nektar Therapeutics (NASDAQ:NKTR) announced that collaborators from the Cairo Laboratory at New York Medical College presented a poster highlighting new preclinical data on NKTR-255 at the 65th American Society of Hematology (ASH) Annual Meeting.
December 11, 2023
·
7 min read
Press Releases
Arcutis Completes Enrollment of Phase 1b Alopecia Areata Study Evaluating ARQ-255
September 5, 2024
·
4 min read
1 of 1,565
Next
